Expert: There is no need to wait for high-priced HPV vaccine


2022-01-23: [Article Link] In recent days, there has been widespread concern about the tight supply of the nine-priced HPV vaccine for women between 16 and 26 years of age, as well as the fact that the vaccine has been on the queue for more than six months, and the introduction of vaccination shaker policies in some areas,…


Note: This is a translated version of the Chinese news media article. A mature and nuanced reading is suggested.



Trending News

What China Reads


Expert: There is no need to wait for high-priced HPV vaccine


2022-01-23: [Article Link] In recent days, there has been widespread concern about the tight supply of the nine-priced HPV vaccine for women between 16 and 26 years of age, as well as the fact that the vaccine has been on the queue for more than six months, and the introduction of vaccination shaker policies in some areas,…

Note: This is a translated version of the Chinese news media article. A mature and nuanced reading is suggested.

Related Articles

Medical Device Observation Phase 5: The industry maintains a high degree of prosperity, and the net profit growth rate of 20 companies including Jiu'an Medical exceeds 100 percent

2022-05-17: Medical Device Observation No. 5: Industry maintains a high-intensity climate, 20 companies with a 100% increase in net profits, including medical treatment for Kyushu. 2022-05-17:10:27:33 Source: Age Business School Source: Time Business School Author: Huang Yuyuan Editor: Sun Yim I.…

"Pharmaceutical Quick-Reading Club" Chengda Pharmaceutical GEM rose over 76 percent on the first day of listing-News-Tianya Pharmaceutical Network

2022-05-17: [20 January 2022/Pharmacological Information at a Glance] The net profit of IXA in 2021 increased by 271.40%-395.19% on a year-on-year basis; JUNG Tsing-Adam's antibiotic analogues were approved for the market; Harbalon, Chief Scientific Officer of GlaxoSchuck, will join you in the daily fresh…

[Foresight Quick Review] Li Keqiang's speech dominates Xi Jinping's brain tumor suspicion?

2022-05-17: Xi Jinping's brain tumor? Update 2022-05-17 8:24 AM My friends, it's Monday, 16 May. Welcome to Vision Rapids. Today’s focus is Xi Jinping’s brain tumor, Li Keqiang’s speech is rare, and a new round of red wall fights is under way. Shanghai’s fight to close down the secret candidate for…
Related Articles

Medical Device Observation Phase 5: The industry maintains a high degree of prosperity, and the net profit growth rate of 20 companies including Jiu'an Medical exceeds 100 percent

2022-05-17: Medical Device Observation No. 5: Industry maintains a high-intensity climate, 20 companies with a 100% increase in net profits, including medical treatment for Kyushu. 2022-05-17:10:27:33 Source: Age Business School Source: Time Business School Author: Huang Yuyuan Editor: Sun Yim I.…

"Pharmaceutical Quick-Reading Club" Chengda Pharmaceutical GEM rose over 76 percent on the first day of listing-News-Tianya Pharmaceutical Network

2022-05-17: [20 January 2022/Pharmacological Information at a Glance] The net profit of IXA in 2021 increased by 271.40%-395.19% on a year-on-year basis; JUNG Tsing-Adam's antibiotic analogues were approved for the market; Harbalon, Chief Scientific Officer of GlaxoSchuck, will join you in the daily fresh…

[Foresight Quick Review] Li Keqiang's speech dominates Xi Jinping's brain tumor suspicion?

2022-05-17: Xi Jinping's brain tumor? Update 2022-05-17 8:24 AM My friends, it's Monday, 16 May. Welcome to Vision Rapids. Today’s focus is Xi Jinping’s brain tumor, Li Keqiang’s speech is rare, and a new round of red wall fights is under way. Shanghai’s fight to close down the secret candidate for…